Funding

NIH Awards Funds To Develop Tuberculosis Treatments

Published in TB and Outbreaks Week, November 4th, 1996

The U.S. National Institutes of Health (NIH) have awarded the National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado, funding to continue research into new ways to treat tuberculosis (TB) in people with AIDS and those not infected with HIV.

"Although tuberculosis steadily declined in the United States until 1985, there has been a resurgence and major outbreaks ever since," said Leonid Heifets, M.D., Ph.D., National Jewish Mycobacteriology Laboratory. "People with compromised immune systems, such as those infected with [HIV], are highly susceptible to tuberculosis and can die in a few months if not properly treated."

The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1996-11-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry